Cleared Traditional

D R Burton OxyPAP (K192000) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K192000 · D R Burton Healthcare, LLC · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2020
Decision
208d
Days
Class 2
Risk

K192000 is an FDA 510(k) clearance for the D R Burton OxyPAP. Classified as Spirometer, Therapeutic (incentive) (product code BWF), Class II - Special Controls.

Submitted by D R Burton Healthcare, LLC (Farmville, US). The FDA issued a Cleared decision on February 19, 2020 after a review of 208 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5690 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all D R Burton Healthcare, LLC devices

Submission Details

510(k) Number K192000 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 2019
Decision Date February 19, 2020
Days to Decision 208 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d slower than avg
Panel avg: 139d · This submission: 208d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BWF Spirometer, Therapeutic (incentive)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BWF Spirometer, Therapeutic (incentive)

All 107
Devices cleared under the same product code (BWF) and FDA review panel - the closest regulatory comparables to K192000.
InSee
K241152 · Tidal Medical Technologies, LLC · Aug 2025
AllPEP
K233855 · Enchant Tek Co. , Ltd. · Feb 2024
LungTrainer (MD2 & MD3)
K221058 · Lung Trainers, LLC · Jul 2023
Breathe+
K222018 · Peep Medical, LLC Dba Go2 Devices · Jun 2023
Hudson RCI Triflo II Incentive Deep Breathing Exerciser
K220565 · Medline Industries, Inc. · Oct 2022
Pulsehaler
K203378 · Respinova, Ltd. · Mar 2021